Skip to content
Bored Studies
RecruitingAccepts healthy volunteers

Noninvasive Brain Stimulation in Adult Amblyopia

Midwestern University · NCT06712849

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 18–55 · All sexes
Healthy volunteers
Accepted
Study type
Interventional · Not applicable
Target enrollment
60
US sites recruiting
1
Study start
May 1, 2024
Record last updated
December 12, 2024

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

The goal of this randomized controlled trial is to investigate the effectiveness of non-invasive brain stimulation in treating adults with amblyopia. The main questions it aims to answer are:

  • What are the effects of non-invasive brain stimulation on neuronal plasticity in the visual cortex of adults with amblyopia, and does it produce lasting changes?
  • Do cumulative sessions of non-invasive brain stimulation influence neural plasticity and higher-order visual functions in adults with amblyopia?

The investigators hypothesize that non-invasive brain stimulation will show a positive cumulative effect after five (5) consecutive days of stimulation on visual perception and function in adults with amblyopia.

Participants will be randomized into one of two treatment groups:

  • High-frequency transcranial random noise stimulation (hf-tRNS).
  • Sham stimulation.

Researchers will compare baseline measurements of crowded visual acuity, contrast sensitivity, stereoacuity, phosphene thresholds, global motion perception, form pattern recognition and pattern-reversal visual evoked potentials (VEPs) to post-treatment measurements for each group.

Being studied: Sham Transcranial Random Noise Stimulation; High Frequency Transcranial Random Noise Stimulation

Conditions: Amblyopia

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

Inclusion Criteria

  • Adults between 18 and 55 years of age
  • Formal diagnosis of amblyopia in one or both eyes of any etiology

Exclusion Criteria

  • History of optic nerve disease, including glaucoma and optic neuritis
  • History of neurological conditions, including demyelinating disease or stroke
  • Presence of metal or electronic implants in or on the body, including pacemakers
  • Taking medications that can affect normal neurological function, including antipsychotics, antiepileptics, and opioids

Recruiting US locations

  • Midwestern University Eye Institute

    Downers Grove, IL 60515

    Site contact: Sherri Olsen · 630-515-7368 · solsen@midwestern.edu

Study contacts (from the official record)

  • Arijit Chakraborty, PhD · 630-960-3172 · achakr@midwestern.edu
  • Adrienne C Quan, OD · 630-960-3183 · aquan@midwestern.edu
Noninvasive Brain Stimulation in Adult Amblyopia (NCT06712849) | Bored Studies